Invention Grant
- Patent Title: Mammalian cell culture-produced neublastin antibodies
-
Application No.: US16230216Application Date: 2018-12-21
-
Publication No.: US10669523B2Publication Date: 2020-06-02
- Inventor: Alan Gilbert , Kyle McElearney , Terrence Michael Dobrowsky , Rashmi Rohit Kshirsagar
- Applicant: GLORIANA THERAPEUTICS SARL
- Applicant Address: US RI Providence
- Assignee: Gloriana Therapeutics, Inc.
- Current Assignee: Gloriana Therapeutics, Inc.
- Current Assignee Address: US RI Providence
- Agency: Lathrop GPM LLP
- Agent Ann-Louise Kerner
- Main IPC: C12N5/00
- IPC: C12N5/00 ; C12P21/00 ; C07K16/22 ; C07K14/755

Abstract:
The present disclosure pertains to a mammalian cell culture genetically modified to express, and which expresses, a neublastin antibody polypeptide, or fragment thereof, in the culture, and to a neublastin antibody polypeptide, or fragment thereof, made by a mammalian cell culture genetically modified to express, and which expresses, the neublastin antibody polypeptide, or fragment thereof.
Public/Granted literature
- US10717965B2 Mammalian cell culture-produced neublastin antibodies Public/Granted day:2020-07-21
Information query